Long term outcome of primary urothelial papilloma: a single institution cohort

被引:8
作者
Al Bashir, Samer [1 ,2 ]
Yilmaz, Asli [1 ,2 ]
Gotto, Geoffrey [3 ]
Trpkov, Kiril [1 ,2 ]
机构
[1] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada
[2] Calgary Lab Serv, Calgary, AB T2V 1P9, Canada
[3] Univ Calgary, Div Urol, Calgary, AB, Canada
关键词
Papilloma; progression; recurrence; urinary bladder; urothelial neoplasm; urothelial papilloma; URINARY-BLADDER; CLASSIFICATION; EXPRESSION; CARCINOMA; GRADE;
D O I
10.1097/PAT.0000000000000029
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aim of this study was to investigate the long term outcome of primary urothelial papilloma (UP). We retrieved 41 primary UR diagnosed between January 2000 and December 2009. Follow-up was obtained by searching pathology and clinical electronic databases. Mean patient age was 57 years (range 30-84 years), with a male-to-female ratio of 1.9:1. Mean follow-up was 81 months (range 3-127 months). In 37 (90.2%) patients, no recurrence and/or progression were documented and no subsequent higher grade neoplasms were diagnosed. Three male patients were diagnosed with UP at 1, 31, and 43 months after the initial resection; the repeat diagnosis of UP at 1 month likely represented an incomplete resection. Thus, only two of 41 patients (4.9%) had a recurrent UP. One of these patients had a subsequent papillary urothelial neoplasm of low malignant potential (PUNLMP), 17 months after the recurrent UP (48 months after the initial UP). Only one additional male had a subsequent PUNLMP, 76 months after the initial UP Thus, only two of 41 patients (4.9%) had a subsequent PUNLMP, both presenting with haematuria. Primary UP does not progress to UC when diagnosed using strict criteria, when no previous or concurrent neoplasms are documented, and when complete initial resection is performed.
引用
收藏
页码:37 / 40
页数:4
相关论文
共 18 条
[1]   Inverted urothelial papilloma of the urinary bladder with focal papillary pattern: a previously undescribed feature [J].
Albores-Saavedra, Jorge ;
Chable-Montero, Fredy ;
Hernandez-Rodriguez, Oscar X. ;
Montante-Montes de Oca, Daniel ;
Angeles-Angeles, Arturo .
ANNALS OF DIAGNOSTIC PATHOLOGY, 2009, 13 (03) :158-161
[2]  
Bergkvist A, 1965, Acta Chir Scand, V130, P371
[3]  
BOSTWICK DG, 1992, J CELL BIOCHEM, P31
[4]  
Cheng L, 1999, CANCER, V86, P2098, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2098::AID-CNCR30>3.3.CO
[5]  
2-0
[6]  
Chow NH, 2000, INT J CANCER, V89, P514, DOI 10.1002/1097-0215(20001120)89:6<514::AID-IJC8>3.3.CO
[7]  
2-8
[8]  
Cubilla A., 2004, WHO CLASSIFICATION T, P89, DOI DOI 10.1016/J.UROLOGY.2004.09.048
[9]   Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia [J].
Desai, S ;
Lim, SD ;
Jimenez, RE ;
Chun, T ;
Keane, TE ;
McKenney, JK ;
Zavala-Pompa, A ;
Cohen, C ;
Young, RH ;
Amin, MB .
MODERN PATHOLOGY, 2000, 13 (12) :1315-1323
[10]  
EBLE JN, 1989, SEMIN DIAGN PATHOL, V6, P351